Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Stanford Medicine · Stanford University · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,074
total citations
- FWCI
- 25.05
- Percentile
- 100%
- References
- 64
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Rituximab
- CD47
- Lymphoma
- Monoclonal antibody
- Antibody
- Immunology
- CD20
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.